共 151 条
[1]
Cheson BD(2014)Recommendations for initial evaluation, staging, and response assessment of Hodgkin and Non-Hodgkin lymphoma: the Lugano classification J Clin Oncol 32 3059-68
[2]
Fisher RI(2007)Diffusion-weighted MRI in the body: applications and challenges in oncology Am J Roentgenol 188 1622-35
[3]
Barrington SF(2014)Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: comparison with CT in a prospective multicenter study J Magn Reson Imaging 40 26-36
[4]
Cavalli F(2010)Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma Eur Radiol 20 2027-38
[5]
Schwartz LH(2011)Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT AJR Am J Roentgenol 196 662-9
[6]
Zucca E(2013)Summary report of the First International Workshop on PET/MR imaging, March 19–23, 2012, Tübingen, Germany Mol Imaging Biol 15 361-71
[7]
Koh D-M(2013)Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? Eur J Nucl Med Mol Imaging 40 373-85
[8]
Collins DJ(2012)Discrimination and anatomical mapping of PET-positive lesions: comparison of CT attenuation-corrected PET images with coregistered MR and CT images in the abdomen Eur J Nucl Med Mol Imaging 40 44-51
[9]
Kwee TC(2013)PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine MAGMA 26 25-35
[10]
Vermoolen MA(2014)FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 Eur J Nucl Med Mol Imaging 42 328-54